Literature DB >> 1947786

Gut lavage fluid proteins as markers of activity of inflammatory bowel disease.

S O'Mahony1, C P Choudari, J R Barton, S Walker, A Ferguson.   

Abstract

Intestinal secretions may be obtained by gut lavage using a polyethyleneglycol-based electrolyte lavage solution; concentrations of immunoglobulins and other proteins are readily measured in processed gut lavage fluid. As patients with inflammatory bowel disease (IBD) have greatly increased numbers of IgG-producing intestinal immunocytes, we measured gut lavage fluid IgG levels in 44 patients with IBD with various degrees of disease activity to determine whether total IgG in gut lavage fluid reflects disease activity. We also measured levels of albumin in gut lavage fluid, to determine the degree of plasma leakage. Both IgG and albumin levels in the patients with active IBD were significantly higher than those in controls and patients with inactive IBD (all p less than 0.00001). IgG is a more specific index of disease activity than albumin, with no overlap between levels in controls and patients with active IBD. There was a positive correlation (r = 0.68, p less than 0.0001) between IgG and albumin levels, suggesting that gut lavage fluid IgG is mainly plasma-derived.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1947786     DOI: 10.3109/00365529108996246

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.

Authors:  R Troncone; N Caputo; A Campanozzi; M Cucciardi; V Esposito; R Russo; B De Vizia; L Greco; S Cucchiara
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.

Authors:  D W Hommes; J Meenan; M de Haas; F J ten Kate; A E von dem Borne; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

3.  Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease.

Authors:  I D Arnott; H E Drummond; S Ghosh
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

4.  Bidirectional small intestinal permeability changes to different-sized molecules after HCl-induced injury in the rat.

Authors:  P D Lundin; B R Weström; N Pantzar; B W Karlsson
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

5.  Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.

Authors:  S O'Mahony; N Anderson; G Nuki; A Ferguson
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 6.  The biophysical principles underpinning muco-trapping functions of antibodies.

Authors:  Alison Schaefer; Samuel K Lai
Journal:  Hum Vaccin Immunother       Date:  2021-07-27       Impact factor: 4.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.